Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?
about
The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literaturePrevalence of chronic pain with neuropathic characteristics: a randomized telephone survey among medical center patients in KuwaitReliability and Validity of the Medical Outcomes Study Short Form-12 Version 2 (SF-12v2) in Adults with Non-Cancer PainPharmacist-led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trialThe burden of disease in patients eligible for mentalization-based treatment (MBT): quality of life and costs.Assessing Health-Related Quality of Life of Chinese Adults in Heilongjiang Using EQ-5D-3L.Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).Health-related quality of life in pregnant women living with HIV: a comparison of EQ-5D and SF-12.Assessment and treatment at a pain clinic: A one-year follow-up of patients with chronic pain.Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain.Peripherally Acting μ-Opioid Receptor Agonists Attenuate Ongoing Pain-associated Behavior and Spontaneous Neuronal Activity after Nerve Injury in Rats.The impact of relocation of chronic pain service from hospital setting to community centre on patient experience: a single-centre audit
P2860
Q26773044-B9FA5867-DB3E-4798-9B65-CF9C91717E34Q33553691-9A2C9232-E8F6-40FE-8B8C-668BD6D30290Q33855979-FDD69151-756C-45A0-B986-56451023E5D1Q35332542-AD7F3190-5047-4D4A-846E-3989E7527E6DQ37336798-DAC9BD83-5B97-479B-AB23-9BEE6AD747D6Q37724429-6B792676-6E32-4967-ACC5-023A715945C4Q39530911-EBD58DCF-5C4B-42E6-A7C6-DD39751840D4Q40075909-3C009C6C-4ED2-4684-A0DE-5390ED3E5B23Q47328334-2150BC3A-F7F4-4E73-B67E-E637C1A9C91DQ47598680-A5E7633F-2DE7-4D9F-9E05-3DC72B8B719EQ53422317-F6620B8B-1500-4133-8A58-5813ED40980FQ57786850-21EE7BAC-75CE-484A-9513-945D4B783B5E
P2860
Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@ast
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@en
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@en-gb
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@nl
type
label
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@ast
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@en
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@en-gb
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@nl
prefLabel
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@ast
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@en
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@en-gb
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@nl
P2093
P2860
P50
P921
P1154
2-s2.0-84908107198
P1433
P1476
Estimating the burden of disea ...... en the EQ-5D and SF-6D matter?
@en
P2093
Ebenezer Afolabi
Kenny D Lawson
Michael G Serpell
P2860
P304
P356
10.1016/J.PAIN.2014.07.001
P407
P5530
P577
2014-07-11T00:00:00Z
P5875
P6179
1051944538